Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This experimental topical ointment is a combination therapy consisting of an ethanol extract of *Azadirachta indica* (neem) leaves and 6% salicylic acid. Developed by researchers at Bangabandhu Sheikh Mujib Medical University (BSMMU) in Dhaka, Bangladesh, it is specifically investigated for the treatment of palmar arsenical keratosis, a condition caused by chronic exposure to arsenic-contaminated drinking water. The salicylic acid component serves as a keratolytic agent to soften and remove hyperkeratotic tissue, while the neem extract is believed to provide anti-inflammatory and antimicrobial benefits. Clinical studies have demonstrated that the combination significantly reduces the size of keratotic nodules compared to salicylic acid monotherapy, showing approximately 79% improvement over a 12-week treatment period.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Azadirachta indica leaves extract + salicylic acid.